|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_1455 | ED149609 | General Research Use | No | Female | White | 71 | 4 - AREDS AMD Severity Scale Step 2 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2990 | ED149543 | General Research Use | No | Female | White | 60 | 4 - AREDS AMD Severity Scale Step 3 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_3752 | ED148923 | General Research Use | No | Male | White | 75 | 4 - AREDS AMD Severity Scale Step 4 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_4056 | ED149401 | General Research Use | No | Male | White | 79 | 4 - AREDS AMD Severity Scale Step 4 | 4 - AREDS AMD Severity Scale Step 4 |
| AR2_2842 | ED149451 | General Research Use | No | Male | White | 78 | 4 - AREDS AMD Severity Scale Step 4 | 4 - AREDS AMD Severity Scale Step 4 |
| AR2_3106 | ED149568 | General Research Use | No | Male | White | 81 | 4 - AREDS AMD Severity Scale Step 4 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_3135 | ED148472 | General Research Use | No | Female | White | 73 | 4 - AREDS AMD Severity Scale Step 4 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_3756 | ED148301 | General Research Use | No | Female | White | 68 | 4 - AREDS AMD Severity Scale Step 4 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_0948 | ED148457 | General Research Use | No | Male | White | 62 | 4 - AREDS AMD Severity Scale Step 1 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_1879 | ED148711 | General Research Use | No | Female | White | 69 | 4 - AREDS AMD Severity Scale Step 4 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_3844 | ED149129 | General Research Use | No | Male | White | 59 | 4 - AREDS AMD Severity Scale Step 4 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_3936 | ED149298 | General Research Use | No | Female | White | 78 | 4 - AREDS AMD Severity Scale Step 3 | 3 - AREDS AMD Severity Scale Step 3 |
| AR2_0561 | ED148304 | General Research Use | No | Male | White | 63 | 4 - AREDS AMD Severity Scale Step 1 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1025 | ED148764 | General Research Use | No | Female | White | 68 | 4 - AREDS AMD Severity Scale Step 4 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_4033 | ED149184 | General Research Use | No | Female | White | 74 | 4 - AREDS AMD Severity Scale Step 1 | 3 - AREDS AMD Severity Scale Step 3 |
| AR2_2374 | ED148287 | General Research Use | No | Female | White | 80 | 4 - AREDS AMD Severity Scale Step 4 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_4105 | ED149265 | General Research Use | No | Male | Black or African American | 68 | 4 - AREDS AMD Severity Scale Step 4 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_2052 | ED148346 | General Research Use | No | Female | White | 66 | 4 - AREDS AMD Severity Scale Step 3 | 3 - AREDS AMD Severity Scale Step 3 |
| AR2_2824 | ED148784 | General Research Use | No | Female | White | 69 | 4 - AREDS AMD Severity Scale Step 1 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0356 | ED148455 | General Research Use | No | Female | White | 76 | 4 - AREDS AMD Severity Scale Step 3 | 4 - AREDS AMD Severity Scale Step 4 |